Maker of Antibody Cocktail Trump Took Seeks Emergency Use OK | Health News

By Robin Foster and E.J. Mundell
HealthDay Reporters

(HealthDay)

THURSDAY, Oct. 8, 2020 (HealthDay News) — Regeneron Pharmaceuticals Inc. said Wednesday that it is seeking emergency approval from the U.S. Food and Drug Administration for an experimental antibody cocktail given to President Donald Trump shortly after he was diagnosed with COVID-19.

Hours before the company made the announcement, Trump proclaimed in a video released by the White House that the drug had an “unbelievable” effect on his recovery from coronavirus infection, the Washington Post reported.

“I think this was the key,” Trump said, after acknowledging that the antibody cocktail was one of several drugs he was prescribed by his medical team. While there is no hard evidence yet proving the drug’s effectiveness in humans, it has shown promise in treating mild cases of the new coronavirus, the Post reported.

In his video, Trump said, “I have emergency-use authorization all set,

Read More

Israeli baby formula maker Else to complete share offering this week

TEL AVIV (Reuters) – Israel’s Else Nutrition BABY.V, which has developed a plant-based infant formula not made from soy, plans to complete a C$25.7 million ($19.3 million) private placement of its shares this week, its chief executive said.

Shareholder H&H International Holding 1112.HK of Hong Kong has bought 11.6% of the shares offered, while Canaccord Genuity CF.TO has taken the rest to sell to investors, Else CEO Hamutal Yitzhak told Reuters.

Else’s formula, made from almonds, buckwheat and tapioca, is organic, vegan and gluten free. Many babies allergic to cow’s milk are also allergic to soy-based formula, Yitzhak said.

“Currently cow’s milk accounts for more than 90% of the market and soy protein for less than 10%,” she said.

Almond is 10 times less allergenic than cow’s milk among babies, according to a 201‮8‬ U.S. allergy prevalence study, said Yitzhak, former head of infant nutrition at Abbott Labs Israel.

Read More